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Graphene-based nanomaterials are increasingly engineered as components of
biosensors, interfaces or drug delivery platforms in neuro-repair strategies. In these
developments, the mostly used derivative of graphene is graphene oxide (GO). To tailor
the safe development of GO nanosheets, we need to model in vitro tissue responses,
and in particular the reactivity of microglia, a sub-population of neuroglia that acts as the
first active immune response, when challenged by GO. Here, we investigated central
nervous system (CNS) tissue reactivity upon long-term exposure to GO nanosheets
in 3D culture models. We used the mouse organotypic spinal cord cultures, ideally
suited for studying long-term interference with cues delivered at controlled times and
concentrations. In cultured spinal segments, the normal presence, distribution and
maturation of anatomically distinct classes of neurons and resident neuroglial cells are
preserved. Organotypic explants were developed for 2 weeks embedded in fibrin glue
alone or presenting GO nanosheets at 10, 25 and 50 µg/mL. We addressed the impact
of such treatments on premotor synaptic activity monitored by patch clamp recordings of
ventral interneurons. We investigated by immunofluorescence and confocal microscopy
the accompanying glial responses to GO exposure, focusing on resident microglia,
tested in organotypic spinal slices and in isolated neuroglia cultures. Our results suggest
that microglia reactivity to accumulation of GO flakes, maybe due to active phagocytosis,
may trim down synaptic activity, although in the absence of an effective activation of
inflammatory response and in the absence of neuronal cell death.
Keywords: graphene oxide, organotypic cultures, patch-clamp, microglia, microvesicles
INTRODUCTION
Graphene is a monolayer sheet of carbon atoms, tightly bound in a hexagonal honeycomb lattice.
More specifically, graphene is an allotrope of carbon in the form of a two-dimensional film of sp2
hybridized carbon atoms (Sanchez et al., 2012; Kostarelos and Novoselov, 2014), characterized
by high mechanical strength and electrical conductivity, combined with optical transparency. In
neurobiology, graphene has been used in surface engineering of regenerative scaffolds to control the
neuro-induction of stem cells (Wang et al., 2012), and in that of neurological interfaces to improve
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electrode performance (Wang et al., 2011; Li et al., 2013; Mao
et al., 2013; Kostarelos and Novoselov, 2014).
Graphene oxide (GO) is the most common derivative
of graphene. Recently, GO materials have been successfully
designed for drug delivery applications (Yang et al., 2008, 2011;
Liu et al., 2013; Baldrighi et al., 2016; Rauti et al., 2018).
However, their potential persistence in biological tissues requires
investigating their safety. We have previously (Rauti et al., 2016)
reported the ability of small GO (<200 nm; s-GO) nanosheets
to reduce synaptic activity at glutamatergic synapses without
affecting cultured hippocampal neurons survival. To date, only
few studies addressed the interaction between s-GO nanosheets
and synapses (Bramini et al., 2016; Rauti et al., 2016), while
there are scarcely any data on the interactions between neural
circuit function, s-GO tissue accumulation and inflammation.
Before any further exploitation of s-GO in synaptic targeting,
a detailed analysis of tissue responses to s-GO exposure is
needed.
Mechanistic studies of the interplay between s-GO, the
activation of microglia and synaptic function, may require
in vitro models to interrogate central nervous system (CNS)
responses at cellular resolution. Organotypic slices are explant
cultures that preserve key, structural elements of the tissue
of origin (Hailer et al., 1996; Fischer et al., 1998; Tscherter
et al., 2001; Schermer and Humpel, 2002; Avossa et al.,
2003, 2006; Furlan et al., 2007; Medelin et al., 2016) allowing
detailed studies of cellular and subcellular responses, such as
inflammatory reactivity and synaptic efficacy (Medelin et al.,
2018), upon chronic treatments, including the exposure to
exogenous factors. In the CNS, the immune response is mediated
by resident macrophages called microglia that are approximately
12% of the total CNS cells originating from myeloid cells. This
subpopulation of brain cells can switch between two different
phenotypes: a ramified phenotype, typical of the resting state,
during which they ‘‘monitor’’ the surrounding environment
(Davalos et al., 2005; Nimmerjahn et al., 2005; Cherry et al.,
2014) and an ameboid phenotype, which is induced by
antigen-mediated stimulation.When activated, microglia rapidly
changes its surface receptor expression and the production of
molecules involved in the immune response, like cytokines and
chemokines (Fetler and Amigorena, 2005; Nimmerjahn et al.,
2005). Activated microglia may represent an active player in
neuron damage (Block et al., 2007).
We used mouse spinal organotypic cultures to mimic a
chronic accumulation of s-GO in the spinal cord tissue. The
s-GO nanosheets were delivered to the spinal tissue upon
dilution in the chicken plasma (fibrin glue) used to embed the
explants for culturing, thus allowing s-GO to rapidly adsorb
proteins (Bertrand et al., 2017), to mimic how nanosheets
behave in a complex biological milieu.We patch-clamped ventral
interneurons to monitor synaptic transmission. Contextually,
using confocal microscopy we explored the effects of s-GO on
innate immunity, in both organotypic slices and primary isolated
microglial cultures. We conclude that chronic accumulation
of s-GO, due to localization of high doses of the material,
significantly affected synaptic activity and the microglia cell
population. Our experiments in isolated microglial cells in
culture support the direct response of these cells to s-GO in
these experimental conditions, however in organotypic cultures
we did not detect strong indicators of a switch toward the
pro-inflammatory phenotype.
MATERIALS AND METHODS
Preparation of s-GO
Synthesis and characterization of s-GO used in the present
study were fully described in a separate article (Rodrigues et al.,
2018). Briefly, 0.8 g of graphite flakes (Graflake 9580, Nacional
Grafite Ltda., Brazil) were oxidized after mixing with 0.4 g of
sodium nitrate (Merck-Sigma, UK) and 18.4 mL of sulfuric acid
99.999% (Merck-Sigma, UK), followed by 2.4 g of potassium
permanganate (Merck-Sigma, UK), according to the modified
Hummers method, which was described in our previous work
(Ali-Boucetta et al., 2013; Rauti et al., 2016). After mixing
for 30 min, 37.5 mL of water for injections (Fresenius Kabi
Ltd., UK) were added dropwise to ensure the safety of the
exothermic reaction taking place. The reaction temperature was
further increased to 98◦C, and maintained for another 30 min.
The reaction was terminated after adding 112.5 mL of water
for injections, followed by the dropwise addition of 12.5 mL
of hydrogen peroxide 30% (Merck-Sigma, UK). The resulting
mixture was purified by several rounds of centrifugation at
9,000 rpm for 20 min, until the supernatant reached a neutral
pH and a viscous orange/brown layer of pure GO appeared
on top of the pelleted oxidation byproducts (Jasim et al., 2016;
Rauti et al., 2016). GO was exfoliated using warm water for
injections and purified by centrifugation at 4,000 rpm for 20 min
to remove any residual graphitic impurities. The obtained GO
dispersion was aliquoted to depyrogenated glass vials, which
were exposed to a water bath sonicator (VWR, UK) operating
at 80 W (45 kHz) for 5 min. The sonicated dispersion was
then centrifuged at 13,000 rpm for 5 min, and the supernatant
was collected yielding s-GO nanosheets. All procedures were
conducted under endotoxin-free conditions, which were attained
by setting the reaction under a laminar flow hood, using
depyrogenated glassware and nonpyrogenic plastic containers
(Mukherjee et al., 2016).
Atomic force microscopy (AFM) images of s-GO were
acquired using a Multimode 8 microscope (Bruker, UK),
operating in tapping mode using OTESPA tips (Bruker, UK).
Twenty microliter of s-GO, diluted to a concentration of 100
µg/mL, were deposited on top of a freshly prepared mica
surface (Agar Scientific, UK) coated with poly-L-lysine (Sigma-
Aldrich, UK), and dried overnight at 37◦C prior to analysis.
Full physicochemical characterization of s-GO is summarized in
Supplementary Figure S1.
Preparation of Spinal Tissue Slices and
Primary Glial Cultures
Organotypic cultures were obtained from spinal cords isolated
from E12 embryonic mouse (C57Bl), as previously described
(Avossa et al., 2003; Furlan et al., 2005, 2007; Usmani et al., 2016).
Briefly, pregnant mice were sacrificed by CO2 overdose and
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decapitation and fetuses delivered by cesarean section. Isolated
fetuses were decapitated and their backs were isolated from
low thoracic and high lumbar regions and transversely sliced
(275 µm) with a tissue chopper. Cultures were fixed on a
glass coverslip (Kindler, EU) with fibrin glue, i.e., reconstituted
chicken plasma (Rockland) clotted with thrombin (Merk). In
graphene-treated cultures, s-GO (Rauti et al., 2016) nanosheets
were embedded in the fibrin glue at 10, 25 and 50 µg/mL final
concentration. The distribution of s-GO within this matrix was
detected via confocal microscopy under reflection mode (see
below; and Patskovsky et al., 2015). Supplementary Figure S2
shows the dispersion of s-GO at the different concentrations.
Experiments were performed on control and s-GO treated
cultures after 2 and 3 weeks in vitro.
All experiments were performed in accordance with the EU
guidelines (Directive 2010/63/EU) and Italian law (decree 26/14)
and were approved by the local authority veterinary service and
by our institution (SISSA-ISAS) ethical committee. All efforts
were made to minimize animal suffering and to reduce the
number of animal used. Animal use was approved by the Italian
Ministry of Health, in agreement with the EU Recommendation
2007/526/EC.
Primary brain glial cultures were obtained from P2 to
P3 rats (Wistar) cortices, as previously described (Calegari et al.,
1999; Rauti et al., 2016). Dissociated cells were plated into
plastic 75 cm2 flasks, incubated (37◦C; 5% CO2) in culture
medium consisting of DMEM (Invitrogen, Carlsbad, CA, USA),
supplemented with 10% fetal bovine serum (FBS), 100 IU/mL
penicillin, and 10 mg/mL streptomycin.
Confluent mixed glial cultures from days in vitro (DIV) 21 to
DIV 25 were treated with a trypsin solution (0.25% trypsin, 1mM
EDTA in HBSS) diluted 1:4 in PBS for 30 min at 37◦C and 5%
CO2. The medium was then collected and diluted 1:4 in DMEM
supplemented with 10% FBS and centrifuged for 5 min at 200× g.
The pellet was then re-suspended in DMEM supplemented with
10% FBS and mixed glial cultures conditioned medium (50:50)
and plated on poly-L-lysine-coated glass coverslips. Twenty-four
hours after trypsinization half of the cultures were incubated with
s-GO at a concentration of 10 µg/mL suspended in the culture
medium for 1 or 5 days.
Electrophysiological Recordings
For patch-clamp recordings (whole-cell, voltage clamp mode), a
coverslip with the spinal culture was positioned in a recording
chamber, mounted on an inverted microscope (Eclipse TE-200,
Nikon, Japan) and superfused with control physiological saline
solution containing (in mM): 152 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2,
10 HEPES and 10 Glucose. The pH was adjusted to 7.4 with
NaOH (osmolarity 305 mosmol L−1). Cells were patched with
glass pipettes (4–7 MΩ) filled with a solution of the following
composition (in mM): 120 Kgluconate, 20 KCl, 10 HEPES,
10 EGTA, 2MgCl2 andNa2ATP. The pHwas adjusted to 7.3 with
KOH (295 mosmol L−1). All electrophysiological recordings
were performed at room temperature (RT; 20–22◦C) and the
spontaneous synaptic activity was recorded by clamping the
membrane voltage at −56 mV (not corrected for liquid junction
potential, which was −14 mV). Recordings were performed
from ventrally located spinal interneurons identified on the
basis of previously reported criteria (Ballerini and Galante, 1998;
Ballerini et al., 1999; Galante et al., 2000). We detected no
differences between controls (n = 45) and s-GO (n = 39) neurons
in cell membrane capacitance (70 ± 8 pF controls, 68 ± 6 pF
s-GO) and membrane input resistance (250 ± 28 MΩ controls,
242 ± 20 MΩ s-GO). Spontaneous activity was also recorded in
the presence of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX,
10 µM), bicuculline (20 µM) and strychnine (10 µM)
to pharmacologically discriminate between glutamatergic and
GABAergic postsynaptic currents (PSCs), respectively. To detect
miniature PSCs (mPSCs), tetrodotoxin (TTX, 1 µM; Latoxan,
Valence, France) was added. All reagents were purchased from
Sigma-Aldrich, if not otherwise indicated. Data were collected
by Multiclamp 700B patch amplifier (Axon CNS, Molecular
Devices, San Jose, CA, USA) and digitized at 10 kHz with
the pClamp 10.2 software (Molecular Devices LLC, San Jose,
CA, USA). All recorded events were analyzed offline with the
AxoGraph 1.4.4 (Axon Instrument) event detection software
(Axon CNS, Molecular Devices, San Jose, CA, USA).
Immunofluorescence Labeling of Spinal
Cord Slices
Organotypic cultures were fixed by 4% formaldehyde (prepared
from fresh paraformaldehyde; Sigma) in PBS for 1 h at RT and
then washed in PBS. Free aldehyde groups were quenched in
0.1 M glycine in PBS for 5 min. The samples were blocked
and permeabilized in 3% FBS, 3% BSA and 0.3% Triton-X
100 in PBS for 1 h at RT. Samples were incubated with primary
antibodies (mouse anti-neurofilament H Smi 32, Biolegend,
1:250 dilution; mouse monoclonal anti-GFAP, Invitrogen,
1:500 dilution; rabbit monoclonal anti-caspase 3, Euroclone,
1:200 dilution; rabbit polyclonal anti-β-tubulin III, Sigma-
Aldrich, 1:250 dilution; rabbit anti Iba1, Wako, 1:250 dilution)
diluted in PBS with 5% FBS at 4◦C, overnight. Samples were then
incubated in secondary antibodies (Alexa 488 goat anti-mouse,
Invitrogen, 1:500 dilution; Alexa 594 goat anti-rabbit, Invitrogen,
1:500 dilution), and DAPI (Invitrogen, dilution 1:200) to stain
the nuclei, for 2 h at RT and finally mounted on 1 mm
glass coverslips using Vectashield hardset mounting medium
(Vector Laboratories). Images were acquired using a Nikon
C2 Confocal, equipped with Ar/Kr, He/Ne and UV lasers. Images
were acquired with a 40× (1.4 NA) or 60× (1.5 NA) oil-objective
(using oil mounting medium, 1.515 refractive index). Confocal
sections were acquired every 500 nm and the total Z-stack
thickness (50 µm) was set such that all emitted fluorescence
was collected from the sample. Regions of interest were confined
to the ventral part of slice. Offline analysis was performed
using the open source image-processing package Fiji (Schindelin
et al., 2012) and Volocity software (Volocity 3D image analysis
software, PerkinElmer, Waltham, MA, USA).
Immunofluorescence Labeling of
Neuroglia Primary Cultures
Primary glial and microglial cultures were fixed by 4%
formaldehyde (prepared from fresh paraformaldehyde) in PBS
for 20 min at RT and then washed in PBS. Free aldehyde groups
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were quenched in 0.1 M glycine in PBS for 5 min. The samples
were blocked and permeabilized in 5% FBS, 0.3% Triton-X
100 in PBS for 30 min at RT. Samples were incubated with
primary antibodies (mouse monoclonal anti-GFAP, Invitrogen,
1:500 dilution; rabbit anti Iba1, Wako, 1:250 dilution; mouse
monoclonal anti-bromodeoxyuridine (Brdu), Thermo Fisher,
1:200 dilution) diluted in PBS with 5% FBS at 4◦C, overnight.
Samples were then incubated in secondary antibodies (Alexa
488 goat anti-mouse, Invitrogen, 1:500 dilution; Alexa 594 goat
anti-rabbit, Invitrogen, 1:500 dilution), and DAPI (Invitrogen,
dilution 1:200) to stain the nuclei, for 45 min at RT and finally
mounted on 1 mm thick glass coverslips using Vectashield
mounting medium (Vector Laboratories). Cells densities were
quantified at 20× (0.5 NA) magnification using a DM6000 Leica
microscope (Leica Microsystems GmbH, Wetzlar, Germany). In
order to investigate the internalization of s-GO in microglial
cells, we used the reflection mode property during the
confocal acquisition. Images were acquired using a Nikon
C2 Confocal, equipped with Ar/Kr, He/Ne and UV lasers. Images
were acquired with a 40× (1.4 NA) oil-objective (using oil
mounting medium, 1.515 refractive index). Confocal sections
were acquired every 200 nm and the total Z-stack thickness
20 µm.
Bromodeoxyuridine (BrdU) Incorporation
Microglial primary cultures were incubated with BrdU (Thermo
Fisher, Waltham, MA, USA) diluted in the culture medium
at a final concentration of 10 µM for 24 h. Cells were then
washed with PBS and fixed by 4% formaldehyde (prepared
from fresh paraformaldehyde) for 20 min at RT and then
washed with PBS (three times, 2 min each). Free aldehyde
groups were quenched in 0.1 M glycine in PBS for 5 min.
Cells were then incubated with HCl 1 M for 1 min on ice and
with HCl 2 M for 15 min at 37◦C. Acid was then neutralized
with boric acid 0.1 M for 10 min at RT. The samples were
then blocked and permeabilized in 3% FBS and 0.3% Triton-X
100 in PBS for 1 h at RT. Samples were incubated with primary
antibodies at 4◦C overnight (mouse monoclonal anti-BrdU,
1:200 dilution; rabbit anti-Iba1, 1:200 dilution). Samples were
then incubated in secondary antibodies (Alexa 488 goat anti-
mouse, Invitrogen, 1:500 dilution; Alexa 594 goat anti-rabbit,
Invitrogen, 1:500 dilution), and DAPI (Invitrogen, dilution
1:200) to stain the nuclei, for 45 min at RT and mounted on
1 mm thick glass coverslips using Vectashield mounting medium
(Vector Laboratories).
Microvesicle Isolation
Microvesicles (MVs) shedding and detection by western blotting
were performed as previously described (Rauti et al., 2016).
MVs release was induced in 21 DIV microglial cells by the
stimulation with benzoyl-ATP (bzATP; 100 µM) in saline
solution with the following composition: 125 mM NaCl, 5 mM
KCl, 1.2 mM MgSO4, 1.2 mM KH2PO4, 2 mM CaCl2, 6 mM
D-glucose, and 25 mM HEPES/NaOH (pH adjusted to 7.4),
for 30 min at 37◦C and 5% CO2. MVs were then pelleted
by centrifugation (Bianco et al., 2009). Negative controls
were incubated with saline solution without the presence
of bzATP. MVs were re-suspended in lysis buffer (50 mM
Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.1% SDS),
sonicated 3 × 10 s, and then boiled at 95◦C for 5 min.
Samples were run on a 10% polyacrylamide gel and were
blotted onto nitrocellulose filters (Millipore, Italy). Filters were
then blocked in PBS-Tween-20 (0.1%) plus 5% nonfat dry
milk and incubated with the primary antibody antiflotillin-1
(dilution 1:1,000) for 16 h at 4◦C. Specific MV marker
flotillin-1 (del Conde et al., 2005; Al-Nedawi et al., 2008)
was detected with mouse monoclonal antiflotillin-1 (dilution
1:1,000). After three washes with PBS-Tween, filters were
incubated with peroxidase-conjugated anti-mouse secondary
antibody (dilution 1:1,000). Optical density of immunolabeled
ECL-exposed protein bands was measured with UVI-1D
software.
Microglial Morphological Analysis
For morphological analysis cells were fixed and immunostained
for Iba1 andDAPI for nuclei, as described above and images were
acquired with a 40× oil objective. The quantitative analysis of
cell morphology was performed with the particle analysis feature
in Fiji (1.51v) to automatically measure the area, perimeter
and Feret’s maximum diameter. In particular, Feret’s diameter
is described as the greatest distance between any two points
along cell perimeter and is considered as an index of cell length
(Kurpius et al., 2006; Caldeira et al., 2014; Torres-Platas et al.,
2014; Zanier et al., 2015; Mitchell et al., 2018). A more ramified
cell has a higher value for this parameter, while a more ameboid
shape is described by a lower value. We also evaluated the
transformation index (Fujita et al., 1996; Caldeira et al., 2014)
which is calculated as [perimeter of cell (µm)]2/4pi [cell area
(µm2)] and describes the degree of cellular ramification. Cells
with long processes and small cell body display larger values
of the transformation index, which depends on the cell shape
regardless the cell size.
Measurement of Cytokines and
Chemokines
In a small set of experiments an inflammatory response
was induced (Hanisch, 2002), by incubating organotypic
slices, for 6 h, with a cocktail of the following mouse
recombinant cytokines: TNF-α (R&D Systems, #210-TA/CF),
IL-1β (R&D Systems, #M15330), GM-CSF (R&D Systems,
#P04141), 10 ng/mL each, or with lipopolysaccharide (LPS,
1 ng/mL). Inflammatory reaction may be detected by cytokine
and chemokine production. A panel of 12 out of cytokines or
chemokines was measured in organotypic culture supernatants
after 2 weeks culturing, by Luminex based technology, using
a customized Procarta plex Immunoassay kit (Invitrogen,
Carlsbad, CA, USA), following the manufacturer’s protocol. The
following soluble factors were simultaneously measured in 50 µl
of supernatant: IL4, IL6, IL10, IL17, IL21, BAFF, IFNγ, TNFα,
CXCL1, CXCL2, CXCL10, MCP1.
Statistical Analysis
The results are presented as the mean ± SD, if not otherwise
indicated. Statistically significant difference between two data
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sets was assessed by t-statistic, in particular by Student’s t-test
(after checking variances homogeneity by Leven’s test) for
parametric data and by Mann-Whitney’s test for non-parametric
ones (Statistica 6.0—StatSoft, Italy). Differences among multiple
groups were evaluated by F-statistic with two-way ANOVA,
followed by the Holm-Sidak test for multiple comparison
(Sigmaplot 12.0—Systat Software).
A statistically significant difference between two data sets was
assessed and P < 0.05 was considered statistically significant.
In box-plots, the thick horizontal bar indicates the median
value, the cross indicates the mean value, the boxed area extends
from the 25th to 75th percentiles while whiskers from the 5th to
the 95th percentiles.
RESULTS
Long-Term Exposure to High Doses of
s-GO Impaired Network Activity in
Spinal-Cord Organotypic Slices
We first explored the long-term (2 weeks) exposure of neural
tissue to s-GO in 3D tissue cultures. s-GO was delivered to the
neural tissue via the fibrin glue, the thick matrix obtained by
chicken plasma and thrombin in which slices are embedded (see
‘‘Materials and Methods’’ section), that represents the explant
growth environment. Figure 1A shows a reconstruction at low
confocal magnification of a spinal cord slice after 14 days of
growth, labeled for neurofilament H (Smi-32; in green) and for
the nuclei (DAPI, in blue). The entire area of tissue growth is
visualized, and it includes the spinal slice, at the center, and the
outgrowing area comprising the co-cultured dorsal root ganglia
(DRG) and the typical, dense mesh of Smi-32+ neurites in the
surrounding outgrowth belt (Fabbro et al., 2012).
Spinal organotypic slices upon 2 weeks of culturing exhibit an
intense spontaneous synaptic activity (Streit, 1993; Ballerini and
Galante, 1998; Furlan et al., 2007). We patch clamped (sketched
in Figure 1B) visually identified ventral interneurons (at holding
potential, Vh of−56mV) in control cultures (n = 45) and in s-GO
treated ones (n = 52), and we recorded spontaneous, basal PSCs.
Figure 1C shows representative tracings in control (top) and
after exposure to the highest dose (50 µg/mL) of s-GO (bottom).
In all culture groups, PSCs appeared as heterogeneous inward
currents of variable amplitudes, characterized by different kinetic
properties (fast decaying events, with decay time constant (τ) of
6 ± 2 ms and slow decaying events with τ 22 ± 6, n = 15, see
sample in Figure 1C, right panel; Medelin et al., 2018).
The chronic (2 weeks) exposure to low (10 µg/mL) doses
of s-GO did not affect PSCs amplitude and frequency values
(39 ± 7 pA and 23 ± 5 Hz, n = 13) when compared to control
ones (42 ± 6 pA and 24 ± 4 Hz, n = 15; plots in Figure 1D).
Conversely, higher s-GO doses significantly (25 and 50 µg/mL,
P < 0.05 and P < 0.01, respectively; two-way ANOVA) reduced
PSCs frequency (from 24 ± 6 Hz in control to 14 ± 3 Hz,
in s-GO 25 µg/mL, n = 15 and 13; from control 22 ± 8 Hz
to 10 ± 2 Hz in s-GO 50 µg/mL, n = 15 and 13; plot in
Figure 1D, left). Upon s-GO treatments, PSCs decay kinetics
(fast decaying, τ 5 ± 2 ms and slow decaying τ 26 ± 3,
n = 13 at 50 µg/mL, see sample Figure 1C bottom row,
right) and amplitudes were not altered by these treatments
(Figure 1D, right). In 25 and 50 µg/mL s-GO treated cultures
we investigated the amount of neuronal apoptosis in respect to
aged-matched controls by measuring the expression of active
caspase-3 (Cohen, 1997). Active caspase-3 positive cells were
quantified in the ventral spinal horns (Figure 1E, in red). We
detected a comparative amount of apoptotic cells in all conditions
(in control: 15 ± 3 Caspase-3 positive cells/mm2 namely 3.7%
of the total amount of cells, n = 10 visual fields and in s-GO
50 µg/mL; 20 ± 3 Caspase-3 positive cells/mm2, 4.3% of the
cells, n = 10 visual fields; plot in Figure 1E). Thus, s-GO
only when delivered at higher concentrations altered synapse
function, without increasing neuronal cell death.
mPSCs (Figure 2) were recorded in a subset of control
(n = 12) and s-GO treated (n = 13) neurons by application of
TTX (1 µM), to block voltage-gated sodium channels. As this
treatment impairs the generation of action potentials, mPSCs
reflect the stochastic release of vesicles from the presynaptic
terminals at individual synapses impinging onto the recorded
neuron. Their frequency depends on the pre-synaptic release
probability and on the number of synaptic contacts, while their
amplitude depends on postsynaptic receptor sensitivity (Raastad
et al., 1992). In neurons exposed to low (10 µg/mL) s-GO,
mPSCs frequency was not affected (from 19 ± 3 Hz in control
to 15 ± 3 Hz in s-GO treated slices; plot in Figure 2). When
investigating the impact of higher graphene doses (25 and 50
µg/mL), we detected a significant difference (P < 0.05 and
P < 0.01, respectively; two-way ANOVA) in mPSCs frequency
(from 20 ± 3 Hz to 13 ± 2 Hz in s-GO 25 µg/mL and from
16 ± 3 Hz to 6 ± 1 Hz in s-GO 50 µg/mL). s-GO did not affect
the amplitude of the recorded events (from 27± 6 pA in controls
to 32 ± 5 pA in s-GO 10 µg/mL; from 29 ± 5 pA in controls
to 27 ± 4 pA in s-GO 25 µg/mL; from 33 ± 8 pA in controls to
30± 6 pA in s-GO 50 µg/mL).
In s-GO neurons (50 µg/mL) we pharmacologically (see
‘‘Materials and Methods’’ section) isolated AMPA-receptor
(AMPAR) mediated glutamatergic mEPSCs (n = 13) or GABAA-
receptor mediated mIPSCs (n = 13), both detected as inward
currents in our recording conditions (Medelin et al., 2016).
mEPSCs and mIPSCs frequency values were similarly reduced by
s-GO when compared to control slices (for mEPSPs in controls
14 ± 4 Hz, n = 12; in s-GO 7 ± 2 Hz, n = 13; P < 0.05, Student’s
t-test; histograms in Figure 2, bottom-left panel; for mIPSCs in
controls 13 ± 4 Hz, n = 12; in s-GO 5 ± 2 Hz, n = 13; P < 0.05,
Student’s t-test; histograms in Figure 2, bottom-right panel).
s-GO Exposure at High Doses Induced
Microglial Proliferation
To investigate tissue reactivity accompanying s-GO ability to
alter synaptic signaling, we used the highest dose tested, namely
the s-GO at 50 µg/mL. In organotypic slice cultures, neuroglia
resident cells are mainly represented by astrocytes (GFAP
positive cells) and microglia (Iba1 positive cells; Medelin et al.,
2018).
GFAP-positive astrocytes are not immune cells per se, but can,
under certain conditions, contribute to the immune response
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FIGURE 1 | s-graphene oxide (s-GO) reduced basal synaptic activity in a dose-response fashion without inducing cell death in organotypic ventral horns. In (A), low
magnification confocal micrograph of a spinal cord slice culture (14 days in vitro, DIV) immune-labeled for neurofilament H (SMI-32; in green) and nuclei (DAPI; in
blue). Scale bar 500 µm. The arrow head indicates the ventral fissure, localizing the ventral horns, while the arrows the co-cultured dorsal root ganglias (DRGs). In
(B), sketch of the experimental setting for ventral interneuron single cell recordings (modified with permission from Usmani et al., 2016). In (C), tracings represent
spontaneous synaptic activity recorded from ventral interneurons in Control (top) and s-GO treated slices (bottom; 50 µg/mL). On the right panel, isolated fast and
slow postsynaptic currents (PSCs) are shown superimposed (electronic average trace superimposed in white) for the control (top) and s-GO treated (bottom)
recordings (same cells as above). In (D), the plots summarize the average PSCs frequency (left) and amplitude (right) values; note the reduction in PSC frequency
upon s-GO treatments (25 and 50 µg/mL; ∗P < 0.05 and ∗∗P < 0.01). In (E), confocal micrographs visualize caspase-3 positive cells (in red) in the ventral horns,
counter-stained for β-tubulin III (in green, to visualize neurons) in Control (left) and s-GO (50 µg/mL; right) treated slices. Nuclei are visualized by DAPI (blue). Scale
bar: 50 µm. The column plot summarizes the density of caspase and β-tubulin double positive cells; note the absence of statistical significant differences between
the two conditions.
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FIGURE 2 | Miniature PSCs (mPSCs) are down regulated by s-GO in organotypic ventral horns. Sample tracings are mPSCs recorded in Control and s-GO (50
µg/mL) treated cultures (top left panel). Top right: plot reporting mPSCs frequency values in control and in the three different s-GO concentrations tested. Note that
s-GO treatments (25 and 50 µg/mL) significantly decreased the frequency of mPSCs (∗P < 0.05 and ∗∗P < 0.01). Bottom: column plots summarize the average
values of AMPA-glutamate (left; mEPSCs) and GABAA (right, mIPSCs) receptor mediated miniature events, pharmacologically isolated. In s-GO treatments (50
µg/mL) a significant decrease in the frequency of both types of miniature was detected (∗P < 0.05 and ∗∗P < 0.01, respectively).
(Farina et al., 2007). In organotypic cultures upon 2 weeks of
culturing, these cells are usually characterized by a stellate-like
morphology (Figure 3A; Avossa et al., 2003) and their density
was not significantly altered by s-GO treatment (Figure 3A,
right histograms; 500 ± 70 GFAP-positive cells/mm2 in control
and 650 ± 90 GFAP-positive cells in s-GO; n = 13 visual
fields each). Iba1-positive microglia cells are known mediators
of CNS inflammation. In contrast to astrocytes, the density of
Iba1-positive cells was significantly (P < 0.01, Student’s t-test)
increased in slices exposed to s-GO (47 ± 17 Iba1-positive
cells/mm2, n = 10 fields in control and 150 ± 30 Iba1-positive
cells/mm2, n = 11 fields for s-GO; Figure 3B).
To further investigate glia cell reactivity to s-GO treatment
in complex systems, we measured from the spinal cord cultures
supernatant (n = 6 slices for each conditions) the presence of
cytokine and chemokine after 2 weeks of continuous exposure.
In s-GO we detected an increased trend of expression, when
compared to controls, of CXCL2, and MCP1, T lymphocytes
and monocytes recall factors, and IL6, IL10, BAFF and
TNFα, cytokines responsible for pro-inflammatory responses
(IL6, TNFα), regulatory function (IL10) and homeostatic B
cell survival (BAFF), however the profiles of soluble factors
production obtained from our analysis, did not reach statistical
significance (Figure 3C). These observations are in line with a
limited or even absent sustained activation of microglial cells
toward both polarized forms: M1 and M2, or most probably
toward an intermediate one (Kabba et al., 2018).
s-GO Exposure Induces Microglial
Proliferation in Neuroglial Cultures
The increased density of microglial cell in the absence of
significant increased production and release of chemokines
and cytokines after 2 weeks exposure to high s-GO dose,
prompted us to directly investigate the effects of s-GO on
microglial cell types in isolated glial preparations, obtained
from early post-natal rats (P2-P3). Due to the relatively
low-cell density typical of cultures comprising isolated
Iba1-positive cells, as shown in Figure 4A (control), we
exposed the cells for 5 days to a lower (10 µg/mL) dose
of s-GO. s-GO readily increased Iba1-positive cell-density,
as shown in Figure 4A, a response reminiscent of the one
observed in organotypic slices (Figure 3B). In order to
assess whether s-GO sheets induced microglia reactivity,
we analyzed the cellular shape, a traditionally accepted
index of the phenotypes microglia acquires when entrained
in tissue responses. In particular, a highly ramified shape
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FIGURE 3 | Tissue reactivity in organotypic spinal cultures exposed to s-GO at high dose. In (A), GFAP immune-labeling to visualize astrocytes in Control and s-GO
treated slices (50 µg/mL). Both cultures were labeled for GFAP (in green) and nuclei (DAPI; in blue) Scale bar 100 µm. Note that the GFAP+ cell density did not differ
between the two conditions (column plot). In (B), immunofluorescence images are shown to visualize glial and microglial cells in Control and s-GO (50 µg/mL) treated
slices (anti-Iba1, in red; anti-GFAP in green; DAPI in blue). Scale bar 50 µm. Note that Iba1+ cell density was significantly (∗∗P < 0.01) increased by s-GO (50 µg/mL;
right column plot). (C) Plots summarize the Milliplex assay measures to assess the production of the following cytokines in organotypic culture supernatant: IL6, IL10,
TNFα and BAFF and chemokines: CXCL1, CXCL2, CXCL10 and MCP1 in the presence or absence of s-GO, after 2 weeks in vitro. Column graphs report mean
values ± SEM of five independent experiments.
is linked to a surveillant state in which microglia actively
monitors the surrounding environment. On the other hand,
an ameboid phenotype may indicate the transition to the
activated, pro-inflammatory state (Saijo and Glass, 2011).
Consistent with a transformation from a ramified to an
ameboid phenotype, the perimeter, Feret’s maximum diameter
and transformation index (plot in Figure 4B), significantly
decreased (Pperimeter < 0.0001, PFeret’s diameter = 0.0035,
Ptransformation index < 0.0001; Mann-Whitney test) after 6 days
of s-GO exposure, compared to control (n = 10 visual fields for
both conditions; three different cultures series). The measured
parameters reliably describe morphological changes and cell
length. In particular, the Feret’s maximum diameter is defined
as the highest distance between any two points along the
cell perimeter while transformation index describes cellular
ramification.
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FIGURE 4 | Increased cell reactivity in pure microglia cell cultures exposed to s-GO. In (A), immunofluorescence micrographs visualize microglia by Iba1 labeling (in
red) in Control and s-GO treated cultures (10 µg/mL). Scale bar 50 µm. The column graph summarizes microglial density in the two conditions. Note that Iba1+ cell
density is significantly (∗∗∗P < 0.001) higher in cultures treated by s-GO. In (B), high magnification confocal micrographs of Iba1+ cells highlight their morphology in
the two conditions. The right column plots summarizes perimeter, Ferret’s maximum diameter and transformation index, parameters that describe cellular
ramification. All of them are significantly reduced after s-GO exposure (∗∗∗Pperimeter < 0.0001, ∗∗PFeret’s diameter < 0.001, ∗∗∗Ptransformation index < 0.0001; Mann-Whitney
test). In (C), box plots show the bromodeoxyuridine (brdU+)/Iba1+ ratio measured in isolated microglial cultures 24 h and 5 days after s-GO exposure (10 µg/mL;
∗∗∗P < 0.001). In (D), western blot analysis of the Microvesicles (MVs) marker flotillin-1 in each condition. MVs were isolated from glial cultures incubated with s-GO
(10 µg/mL) for 6 days and then treated or not with benzoyl-ATP (bzATP).
Next, we analyzed the number of cycling cells present in
each culture group (control and s-GO). For this purpose, cells
were pulsed at 24 h and at 5 days with 10 mM BrdU prior
to fixation. The number of cells that had incorporated the
nucleotide analog was then assessed by immunofluorescence,
using anti-BrdU-specific antibodies. In Figure 4C the box
plot shows the BrdU+/Iba1+ ratio, an index of microglial
cells that incorporated BrdU in the newly synthesized DNA
during cell division, providing a quantitative measure of
proliferative capacity of cells (Nowakowski et al., 1989). The
higher BrdU+/Iba1+ ratio was already significant at 24 h
of s-GO exposure (medianGO = 0.85; mediancontrol = 0.08),
suggesting an early interaction of microglia with small graphene
sheets. The increased proliferation was more pronounced
after 5 days of incubation with s-GO (medianGO = 0.2;
mediancontrol = 0.45; P < 0.001, Mann-Whitney test, for both
time points; n = 10 fields for each condition; four different
cultures).
MVs, released from almost all cell brain types, are,
in general, an emerging intercellular communication over
long-range distance. In particular, MVs discharged by microglial
cells represent a secretory pathway for inflammatory cytokine
(Turola et al., 2012) potentially promoting propagation of
neuroinflammatory responses in the brain. We measured the
release of MVs from isolated microglial cultures in control
or exposed to s-GO by western blot analysis for the protein
flotillin-1, a marker of lipid rafts that are specific plasma
membrane regions were the probability of MVs release
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is higher (Figure 4D; Rauti et al., 2016). Pharmacological
stimulation by bzATP induces only a slight release of MVs in
isolated microglial cells, as depicted by the particularly weak
signal in the specific band (Figure 4D). Interestingly, bzATP
stimulation in the presence of s-GO triggers a massive microglia
shedding of MVs, shown by the high intensity of the band
(Figure 4D).
Localization of s-GO in Microglial Cells
We then directly investigated the fate of s-GO in isolated
microglia cultures using confocal microscopy reconstructions.
Iba1-positive cells (two different culture series) were exposed
for 3 days to s-GO (10 µg/mL). We tested the presence
of s-GO sheets within Iba1 positive cells by operating the
confocal microscopy under reflection mode, which allows the
visualization of s-GO (Jung et al., 2007; Kim et al., 2010;
Bramini et al., 2016; Chiacchiaretta et al., 2018). Figure 5 shows
confocal reconstructions of control and treated Iba1 positive
cells. In s-GO-treated cells, GO nano-sheet aggregates (in yellow,
reflection mode) were detected inside microglial cells (in gray,
Iba1+) by z-stack reconstruction (Figure 5, top panels: 40×;
100 × 100 µm2 visualized area). In Figure 5, high magnification
confocal micrographs (control and s-GO treated, bottom panels)
are shown (60×; 50× 50 µm2 visualized area) depicting a single
microglia (gray) cell co-localization with the reflected signal
of graphene (yellow). The orthogonal view of the z-projection
shows the XZ and YZ planes (bottom side and right side of
the z-stack reconstructed image, respectively) of the acquired
fields. As expected from cells that act as macrophages, the
material was internalized and stocked inside the cell, forming
small aggregates, appreciable by the orthogonal reconstruction.
The signal of s-GO was not present in control cells, either in the
z-stack reconstruction or in the orthogonal planes (Figure 5, left
panels).
DISCUSSION
We used here organotypic spinal cord cultures to test tissue
responses to s-GO prolonged exposure. In particular, we were
interested in assessing microglia reactivity in cultured neural
explants, where immune resident cells are present, but not
supported by the peripheral ones.
Organotypic spinal slices represent a biological model of
segmental spinal microcircuit useful for studying the dynamics
of intrasegmental processes. A long series of studies has indicated
that the organotypic cultures from mouse spinal cord represent
a valuable in vitro model system to study the mechanisms of
development, neurogenesis, glial differentiation, myelination,
muscle formation, and synaptogenesis leading to early post
natal features, upon 2 weeks of culturing (Avossa et al., 2003;
Rosato-Siri et al., 2004; Fabbro et al., 2007; Furlan et al., 2007;
Sibilla et al., 2009; Medelin et al., 2016). More recently, we
confirmed the presence of heterogeneous neuroglial cells after
2 weeks of in vitro growth and we further documented in
organotypic spinal tissue the induction, by short-term incubation
with pro-inflammatory CKs cocktail, of a reliable release of
cytokines and chemokines, mostly due to the local generation
and delivery of inflammatory factors (Medelin et al., 2018).
Thus, our experimental model is ideally suited to dissect spinal
resident cells ability in modulating local inflammatory tissue
reactivity.
The major result of the present investigation is that the
long-term accumulation of s-GO (when delivered at high doses)
affected resident microglia and, in the absence of an effective
clearance, may induce a subtle, although chronic, reactive state,
potentially trimming down synaptic activity, as physiologically
occurring during development (Paolicelli et al., 2011). In fact,
in our experiments, both GABAR- and AMPAR-mediated
mPSCs were reduced in frequency upon s-GO exposure at
high concentrations. The reduction in miniatures’ frequency,
but not in their amplitude, strongly suggests a reduction in
the number of synapses or of release sites (Rauti et al., 2016).
This down-regulation of synapses is apparently not due to a
general cell membrane disruption or to neuronal apoptosis. In
fact, we never detected alterations in basic electrophysiological
parameters, reflecting neuronal health and membrane integrity
(Carp, 1992; Djuric et al., 2015). This indicated, together with
the absence of up-regulated apoptosis that the synaptic events
diminished not as a consequence of direct neuronal damage
brought about by s-GO.
In organotypic slices, both glutamate- and GABA-mediated
synapses were down-regulated by s-GO, this result differs from
our previous report, where s-GO down-regulated selectively
glutamatergic release sites in hippocampal cultures (Rauti et al.,
2016). Considering the similarity of the s-GO batch used here
compared to our previous study (Supplementary Figure S1),
the lack of specific synaptic targeting may be related to several
factors, such as the diverse CNS regions tested, i.e., ventral
spinal cord vs. hippocampus, the initially more immature stage
of network and synapse development (embryonic vs. postnatal)
or the s-GO higher concentrations. In this context, it is relevant
to note the s-GO delivery modality used here: s-GO was
accumulated in the fibrin glue embedding the spinal culture and,
presumably, was from here released along 2 weeks of culturing.
Thus, the potential formation of a protein corona might have
affected the nanoparticle biological fate (Hadjidemetriou et al.,
2015) favoring active phagocytosis by neuroglia and preventing
the direct synapse interference described in our previous report
(Rauti et al., 2016). It is tempting to speculate that the
presence in the spinal explants of resident neuroglia resulted
in active phagocytosis restricted to intrinsic microglia, without
the involvement of blood cells such as macrophages. Such an
activation could have induced a generic microglia response,
known as synaptic stripping, ultimately leading to indiscriminate
synapse reduction (Kettenmann et al., 2013).
In spinal organotypic slices exposed to s-GO, the presence
of tissue reactivity is indicated only by the observed increase
in microglia cell-density, in the absence of increased GFAP+
astrocytes, suggesting only a mild state of reactivity (Olson,
2010; Liddelow et al., 2017; Okada et al., 2018). Interestingly,
the cytokines and chemokines profiles measured in organotypic
cultures supernatant, although slightly altered, were not
significantly increased after 2 weeks of s-GO exposure. In this
regard, we did not find an increase in IL-6, that is produced by
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FIGURE 5 | s-GO activates microglia phagocytosis in pure neuroglia cultures. Representative confocal reconstruction of microglial cells in Control or s-GO
(10 µg/mL) treated cultures. Scale bar 20 µm. In the bottom panel, for both conditions a 60× zoom (50 × 50 µm field) of a single microglial cell is shown. Scale bar
20 µm. Cultures are immunostained for Iba1 (in gray), and DAPI (in blue), s-GO is visualized by the reflection mode of the confocal system (in yellow). s-GO sheets
are visible as aggregates colored in yellow inside the cell.
astrocyte following, for example, a proinflammatory stimulation
(Ulivieri et al., 2016). Therefore, in this model, we may
hypothesize that microglial proliferative response with no
significant variation in cytokines production after 2 weeks, does
not involve a shift into the M1 phenotype.
The results in this study obtained with isolated Iba1+ cells
are in support of a direct activation of microglial cells as
a consequence of active s-GO phagocytosis. s-GO boosted
microglia proliferation leading to a significantly higher cell
density in pure neuroglia cultures, accompanied by the typical
morphological switch from a ramified to an ameboid phenotype
(Nimmerjahn et al., 2005; Kettenmann et al., 2011; Saijo and
Glass, 2011; Cherry et al., 2014), suggestive of an active role
of Iba1-positive cells in the tissue reaction to graphene, even
in the virtual absence of other cell types. The direct activation
of microglia was apparently related to fast internalization of
s-GO flake aggregates that occurs during the first 24 h after the
exposure.
We thus suggest that s-GO, accumulated via the fibrin glue,
activates resident microglia phagocytosis. This hypothesis is also
supported by the observation that pure microglial cultures grown
and exposed to s-GO in a serum-free medium did not show a
proliferation boost comparable to that found in the presence of
FBS (Supplementary Figure S3). As already discussed above,
the interaction of nanoparticles such as s-GO with biological
fluids may affect their fate and effectiveness. In fact, the corona
formation takes place not only in the presence of plasma proteins
like fibrinogen but also with proteins present in the serum
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(Gräfe et al., 2016). Therefore, the proliferative response found
in both pure microglial cultures and organotypic slices exposed
to s-GO, despite their different origin and architecture, may be
explained by an increase of the efficacy in the uptake of the
material (Walkey et al., 2012) bymicroglia andmediated by s-GO
interactions with the proteins pool of plasma and serum.
An additional indication of microglia reactivity in s-GO
was provided by the increased release of shed vesicles induced
by bzATP. MVs released by microglia have been reported to
affect synaptic activity, mainly acting at the presynaptic site
of the excitatory synapses, but increasing synaptic activity and
glutamate release in primary cultures (Antonucci et al., 2012)
thus it seems unfeasible that the down-regulation in synaptic
activity detected in this study be mediated by MVs release.
One possibility is that, in the current experimental conditions,
the global reduction in synaptic activity is mostly due to
the emergence of chronic, although mild, tissue reactivity.
Such reactivity follows microglia phagocytic activity of protein-
decorated s-GO flakes. Ultimately, we have to ask ourselves
whether these data indicate a potential in vivo inflammatory
response due to s-GO sheets. There are several relevant aspects
that limit reporting it as an inflammatory response. First
of all, the conditions we tested involved the delivering of
s-GO to a ‘‘closed’’ biological system, allowing only resident
macrophages to interact with it and limiting the contribution
of neighbor tissues in the interaction with this material, as it
would happen in an in vivo model. The lack of significance in
the chemokine and cytokine increase in concentration suggests
a mild immune response that may not necessarily lead to
a pathological inflammatory state or alternatively indicates
a return to a physiological condition, from an intermediate
immune activation. Last, astrocytes, which depend on microglia
activation to be polarized to pro-inflammatory cells did not
show, in this context, reactive gliosis. To note, a recent
report (Song et al., 2014) investigated microglia pro- and/or
anti-inflammatory responses when challenged by different
graphene structures, and documented anti-inflammatory effects
of 3D-graphene foams.
Microglia produces immunemediators secondary to neuronal
stimulation, (i.e., tissue injury), or following a direct stimulus
to microglia itself. Here, we report an increased proliferation
rate of Iba1-positive cells, suggestive of microglia activation,
and consistent with morphological observations. However, the
detected cell activation seems to involve a group of cells, not
all of them, and this may explain the fact that we observed
only a trend toward increased production of immune factors,
without significant variations. We may hypothesize that the
fraction of activated microglia includes cells in direct contact to
s-GO. Indeed, microglia is often reported to function similarly
to other myeloid cells, the macrophages, able to scavenge the
environment, perform phagocytosis, antigen presentation and to
react to contact with nano materials (Aldinucci et al., 2013; Jin
and Yamashita, 2016) in order to maintain CNS homeostasis,
with both detrimental and beneficial effects. It is important
to underline that eventually the pro-inflammatory molecules,
present before and after s-GO contact, were not inducing
astrogliosis. Therefore, as a side effect, our in vitro model allows
the direct observation and study of material/neuron interactions
in the presence of glial cells, and also simulates accumulation
of material in CNS providing useful insights on the potential
consequences.
The function of microglia, brain macrophages, is still poorly
understood. Inmice there are at least two subtypes: inflammatory
and non-classical patrolling cells (Nimmerjahn et al., 2005),
and also a CNS region-dependent microglial heterogeneity has
been suggested, suggesting that microglia, although in many
different ways, is constantly activated. In this complex picture,
we were interested in investigating whether s-GO induced an
inflammatory reaction. Our results indicate that this was not the
case. Further studies should indeed address the interplay between
microglia and s-GO, for example by single cell RNA sequencing
(Matcovitch-Natan et al., 2016), a method that has sufficient
sensibility to determine the functional/phenotypic response of
these important brain-macrophage cell population.
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FIGURE S1 | Physicochemical characterization of s-GO. (A) AFM height image
of s-GO used in the present study. (B) Lateral dimension and (C) thickness
distributions of s-GO nanosheets analyzed by AFM. (D) Table summarizes the full
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characterization of the s-GO batch used here and compares with the s-GO used
in our previous study. The similar physicochemical properties of both s-GOs reveal
low batch-to-batch variation.
FIGURE S2 | Confocal reconstructions, acquired via reflection mode
configuration, of s-GO nanosheets dispersed in the fibrin glue at different
concentrations. The image was reconstructed by stitching 3 × 3 visual fields
acquired at 20× magnification. Scale bar: 200 µm.
FIGURE S3 | brdU+/Iba1+ ratio measured in isolated microglial cultures 24 h
after s-GO exposure (10 µg/mL) in a FBS-free medium. No significant differences
were observed between the two conditions (mean ± SEM).
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